{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T22:25:12Z","timestamp":1772663112057,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.humimm.2021.08.006","type":"journal-article","created":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T00:25:12Z","timestamp":1629505512000},"page":"945-949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Assessment of the presence of interleukin 17+ macrophages and Th17 cells in situ in lip and oral tongue cancer"],"prefix":"10.1016","volume":"82","author":[{"given":"Th\u00e2mara Manoela Marinho","family":"Bezerra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e1rbara Vanessa de Brito","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joabe dos Santos","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Arthur Barbosa","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassiano Francisco Weege","family":"Nonaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9ricka Janine Dantas da","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rcia Cristina da Costa","family":"Miguel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.humimm.2021.08.006_b0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/jop.12465","article-title":"Multiple cells express interleukin 17 in oral squamous cell carcinoma","volume":"46","author":"Avadhani","year":"2017","journal-title":"J. Oral. Pathol. Med."},{"key":"10.1016\/j.humimm.2021.08.006_b0010","doi-asserted-by":"crossref","unstructured":"Y. Song, J.M. Yang, Role of interleukin (IL)-17 and T-helper (Th)17 cells in cancer, Biochem. Biophys. Res. Commun. 493 (2017) 1\u20138. 10.1016\/j.bbrc.2017.08.109.","DOI":"10.1016\/j.bbrc.2017.08.109"},{"key":"10.1016\/j.humimm.2021.08.006_b0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cellimm.2017.10.015","article-title":"The paradox of Th17 cell functions in tumor immunity","volume":"322","author":"Asadzadeh","year":"2017","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.humimm.2021.08.006_b0020","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.humimm.2014.01.011","article-title":"Inter-relation of Th1, Th2, Th17 and Treg cytokines in oral cancer patients and their clinical significance","volume":"75","author":"Gaur","year":"2014","journal-title":"Hum Immunol."},{"key":"10.1016\/j.humimm.2021.08.006_b0025","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/08820139.2017.1360344","article-title":"Phenotypic and functional characteristics of Th17 (CD4+ IL17A+) cells in human oral squamous cell carcinoma and its clinical relevance","volume":"46","author":"Gaur","year":"2017","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.humimm.2021.08.006_b0030","doi-asserted-by":"crossref","unstructured":"T. Wei, X. Cong, X.T. Wang, X.J. Xu, S.N. Min, P. Ye, X. Peng, L.L. Wu, G.Y. Yu, Interleukin-17A promotes tongue squamous cell carcinoma metastasis through activating miR-23b\/versican pathway, Oncotarget. 8 (2017) 663-6680. https:\/\/doi.org\/10.18632\/oncotarget.14255.","DOI":"10.18632\/oncotarget.14255"},{"key":"10.1016\/j.humimm.2021.08.006_b0035","doi-asserted-by":"crossref","unstructured":"M.H. Lee, J.T.C. Chang, C.T. Liao, Y.S. Chen, M.L. Kuo, C.R. Shen, Interleukin 17 and peripheral IL-17-expressing T cells are negatively correlated with the overall survival of head and neck cancer patients, Oncotarget. 9 (2018) 9825-9837. https:\/\/doi.org\/10.18632\/oncotarget.23934.","DOI":"10.18632\/oncotarget.23934"},{"issue":"4","key":"10.1016\/j.humimm.2021.08.006_b0040","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00428-018-02517-1","article-title":"Integrating histopathology, immune biomarkers, and molecular subgroups in solid cancer: the next step in precision oncology","volume":"474","author":"Giraldo","year":"2019","journal-title":"Virchows Arch."},{"issue":"9","key":"10.1016\/j.humimm.2021.08.006_b0045","doi-asserted-by":"crossref","first-page":"12223","DOI":"10.1007\/s13277-016-5085-z","article-title":"Feedback mechanisms between M2 macrophages and Th17 cells in colorectal cancer patients","volume":"37","author":"Mao","year":"2016","journal-title":"Tumor Biol."},{"key":"10.1016\/j.humimm.2021.08.006_b0050","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1601-0825.1998.tb00260.x","article-title":"Is the invasive front of an oral carcinoma the most important area for prognostication?","volume":"4","author":"Bryne","year":"1998","journal-title":"Oral Dis."},{"key":"10.1016\/j.humimm.2021.08.006_b0055","doi-asserted-by":"crossref","unstructured":"E.J.D. Silveira, G.P. Godoy, R.D.A. Lins, M.L. Arruda, C.C. Ramos, R.A. Freitas, L.M. Queiroz, Correlation of clinical, histological, and cytokeratin profiles of squamous cell carcinoma of the oral tongue with prognosis, Int. J. Surg. Pathol. 15 (2007) 376\u2013383.https:\/\/doi.org\/10.1177\/1066896907304992.","DOI":"10.1177\/1066896907304992"},{"key":"10.1016\/j.humimm.2021.08.006_b0060","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.3892\/or.2015.4238","article-title":"Involvement of nuclear receptor RZR\/ROR\u03b3 in melatonin-induced HIF-1\u03b1 inactivation in SGC-7901 human gastric cancer cells","volume":"34","author":"Wang","year":"2015","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.humimm.2021.08.006_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00262-011-1151-y","article-title":"Are we ready to start studies of Th17 cell manipulation as a therapy for cancer?","volume":"61","author":"Middleton","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"issue":"5","key":"10.1016\/j.humimm.2021.08.006_b0070","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/hed.25579","article-title":"Impact of varying anatomic sites on advanced stage and survival of oral cancer: 9-year prospective cohort of 27 717 cases","volume":"41","author":"Su","year":"2019","journal-title":"Head Neck."},{"issue":"5","key":"10.1016\/j.humimm.2021.08.006_b0075","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s13402-012-0093-5","article-title":"Skewed immunological balance between Th17 (CD4 IL17A) and Treg (CD4 CD25 FOXP3) cells in human oral squamous cell carcinoma","volume":"35","author":"Gaur","year":"2012","journal-title":"Cell. Oncol."},{"issue":"4","key":"10.1016\/j.humimm.2021.08.006_b0080","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s13402-020-00510-y","article-title":"IL-17A and IL-17F orchestrate macrophages to promote lung cancer","volume":"43","author":"Ferreira","year":"2020","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.humimm.2021.08.006_b0085","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1186\/bcr2195","article-title":"IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines","volume":"10","author":"Zhu","year":"2008","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.humimm.2021.08.006_b0090","first-page":"1603","article-title":"Overexpression of interleukin-17 in tumor-associated macrophages is correlated with the differentiation and angiogenesis of laryngeal squamous cell carcinoma","volume":"125","author":"Meng","year":"2012","journal-title":"Chin. Med. J. (Engl)"},{"key":"10.1016\/j.humimm.2021.08.006_b0095","doi-asserted-by":"crossref","unstructured":"B. Guo, L. Li, J. Guo, A. Liu, J. Wu, H. Wang, J. Shi, D. Pang, Q. Cao, M2 tumor-associated macrophages produce interleukin-17 to suppress oxaliplatin-induced apoptosis in hepatocellular carcinoma, Oncotarget. 8 (2017) 4465\u201344476. https:\/\/doi.org\/10.18632\/oncotarget.17973.","DOI":"10.18632\/oncotarget.17973"},{"key":"10.1016\/j.humimm.2021.08.006_b0100","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.2147\/CMAR.S174899","article-title":"IL-17 induces macrophages to M2-like phenotype via NF-\u03baB","volume":"10","author":"Shen","year":"2018","journal-title":"Cancer Manag. Res."},{"issue":"3","key":"10.1016\/j.humimm.2021.08.006_b0105","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4143\/crt.2014.46.3.297","article-title":"Interleukin-17 indirectly promotes M2 macrophage differentiation through stimulation of COX-2\/PGE2 pathway in the cancer cells","volume":"46","author":"Li","year":"2014","journal-title":"Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.humimm.2021.08.006_b0110","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12013-011-9276-3","article-title":"Expression of Th17 cells in breast cancer tissue and its association with clinical parameters","volume":"62","author":"Yang","year":"2012","journal-title":"Cell. Biochem. Biophys."},{"issue":"2","key":"10.1016\/j.humimm.2021.08.006_b0115","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jss.2012.07.055","article-title":"Prevalence and clinical relevance of Th17 cells in patients with gastric cancer","volume":"178","author":"Yamada","year":"2012","journal-title":"J. Surg. Res."},{"issue":"4","key":"10.1016\/j.humimm.2021.08.006_b0120","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nri2742","article-title":"Th17 cells in tumour immunity and immunotherapy","volume":"10","author":"Zou","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2021.08.006_b0125","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ajpath.2012.08.041","article-title":"The role and regulation of human Th17 cells in tumor immunity","volume":"182","author":"Ye","year":"2013","journal-title":"Am. J. Pathol."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885921002056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885921002056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:55:29Z","timestamp":1759319729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885921002056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0198885921002056"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2021.08.006","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of the presence of interleukin 17+ macrophages and Th17 cells in situ in lip and oral tongue cancer","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2021.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}